Solutions 4 Wealth, LTD Galectin Therapeutics Inc Transaction History
Solutions 4 Wealth, LTD
- $44.1 Billion
- Q2 2024
A detailed history of Solutions 4 Wealth, LTD transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Solutions 4 Wealth, LTD holds 36,085 shares of GALT stock, worth $90,212. This represents 0.18% of its overall portfolio holdings.
Number of Shares
36,085
Previous 36,085
-0.0%
Holding current value
$90,212
Previous $86.2 Million
5.44%
% of portfolio
0.18%
Previous 0.24%
Shares
1 transactions
Others Institutions Holding GALT
# of Institutions
77Shares Held
9.36MCall Options Held
982KPut Options Held
2.7K-
Vanguard Group Inc Valley Forge, PA2.12MShares$5.29 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$3.91 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.13MShares$2.81 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA842KShares$2.1 Million0.0% of portfolio
-
Commonwealth Equity Services, LLC483KShares$1.21 Million0.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $149M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...